描述
Crizalk 250毫克胶囊由辉瑞制药在印度生产,每粒胶囊含有250毫克克唑替尼。每瓶60粒,Crizalk 250毫克胶囊是治疗肺癌的有效选择。购买克唑替尼需要凭医生处方。Indogenmed公司经销各种克唑替尼仿制药。
Rx (Prescription Medicine)
USD $ 3,300.00
USD $ 110.00 per capsule
Crizalk 250毫克胶囊由辉瑞制药在印度生产,每粒胶囊含有250毫克克唑替尼。每瓶60粒,Crizalk 250毫克胶囊是治疗肺癌的有效选择。购买克唑替尼需要凭医生处方。Indogenmed公司经销各种克唑替尼仿制药。
| Brand Name | |
|---|---|
| Pack Quantity | 30 Capsules, 60 Capsules, 90 Capsules |
| Country Of Origin | India |
| Medicine Form | Capsule |
| Medicine Type | Branded |
| Molecule | |
| Packaging Type | Strip |
| Rx Status | Rx (Prescription Medicine) |
| Strength | 250 mg |
只有已购买此产品的登录客户才能发表评价。
其他品牌的 Crizotinib 250 mg — 同一活性成分且强度相同,但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
评价
目前还没有评价